PENSION & WEALTH MANAGEMENT ADVISORS, INC.
PensionPosition in LLY — ELI LILLY & Co
CIK 2145782
WALTHAM, MA
Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$230,290
+$226,611 QoQ
Shares Held
192
+4700.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#4,347
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PENSION & WEALTH MANAGEMENT ADVISORS, INC. holds $2,189,069 across 10 Drug Manufacturers - General names. LLY ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
12,304 | $708,956 | |
| 2 | JNJ |
Johnson & Johnson
|
2,069 | $525,463 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,551 | $456,303 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
192 | $230,290 | |
| 5 | ABBV |
AbbVie Inc.
|
874 | $219,933 | |
| 6 | NVO |
Novo Nordisk A S
|
430 | $20,614 | |
| 7 | PFE |
Pfizer Inc
|
803 | $19,336 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
50 | $6,317 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $230,290 | 192 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,679 | 4 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $4,298 | 4 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $3,052 | 4 | Shares | Sole | 2026-08-07 | |
| 2025-06-30 | $20,267 | 26 | Shares | Sole | 2026-08-07 | |
| 2025-03-31 | $18,170 | 22 | Shares | Sole | 2026-08-07 | |
| 2024-12-31 | $8,492 | 11 | Shares | Sole | 2026-08-07 | |
| 2024-09-30 | $9,745 | 11 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||